Home
Service
Pathology
OUTSOURCE
Immunohistochemistry, Individual Marker, ER (Estrogen Receptor)(J009)-Delhi
Service
Pathology
OUTSOURCE
Immunohistochemistry, Individual Marker, ER (Estrogen Receptor)(J009)-Delhi
OUTSOURCE
Immunohistochemistry, Individual Marker, ER (Estrogen Receptor)(J009)
Also Known As:
ER
IHC Estrogen Receptor
IHC ER
About This Test
Estrogen receptor (ER) is a steroid hormone receptor commonly used alongwith Progesterone receptor (PR) in the management of women with breast cancer. ER & PR status provides an indication of prognosis and potential benefit from hormonal therapy. Generally ER & PR positive tumors are more likely to respond to endocrine therapy and have a better prognosis, stage for stage as compared to receptor negative tumors. This test is also recommended for patients with Ductal carcinoma in situ (DCIS) to predict potential benefit of endocrine therapies.
Test Parameters (1)
- IMMUNOHISTOCHEMISTRY, INDIVIDUAL MARKER, ER (ESTROGEN RECEPTOR)
Home Collection
✓ Available
Reports Available In
7 Days
Frequently Asked Questions
Outsourced test are being done from Dr. Lal Path Lab. Charges and reporting time is same as of Dr. Lal Path Labs.
Provide a copy of the Histopathology report.
Estrogen receptor (ER) is a protein found on the surface or inside some breast cancer cells that allows them to respond to the hormone estrogen. IHC testing measures ER expression in tumor tissue, which is crucial for diagnosis, prognosis, and treatment planning.
TAT Policy
The Turnaround Time (TAT) depends on the following factors:
- Registration date and time
- Type of scan or test
- Scan time or sample collection time
In uncommon circumstances, TAT may be delayed due to test complexity or reasons beyond our control. You will be informed of the estimated TAT at the time of registration.
